NO20043774L - The use of devazenide as analgesic agent - Google Patents

The use of devazenide as analgesic agent

Info

Publication number
NO20043774L
NO20043774L NO20043774A NO20043774A NO20043774L NO 20043774 L NO20043774 L NO 20043774L NO 20043774 A NO20043774 A NO 20043774A NO 20043774 A NO20043774 A NO 20043774A NO 20043774 L NO20043774 L NO 20043774L
Authority
NO
Norway
Prior art keywords
devazenide
analgesic agent
devazepide
analgesically effective
administration
Prior art date
Application number
NO20043774A
Other languages
English (en)
Norwegian (no)
Inventor
Karen Jackson
Original Assignee
Ml Lab Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ml Lab Plc filed Critical Ml Lab Plc
Publication of NO20043774L publication Critical patent/NO20043774L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20043774A 2002-04-09 2004-09-09 The use of devazenide as analgesic agent NO20043774L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0208129.7A GB0208129D0 (en) 2002-04-09 2002-04-09 Method of treatment
PCT/GB2003/001514 WO2003086409A1 (en) 2002-04-09 2003-04-09 The use of devazepide as analgesic agent

Publications (1)

Publication Number Publication Date
NO20043774L true NO20043774L (no) 2005-01-06

Family

ID=9934506

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043774A NO20043774L (no) 2002-04-09 2004-09-09 The use of devazenide as analgesic agent

Country Status (13)

Country Link
EP (1) EP1492540B1 (de)
JP (1) JP2005529106A (de)
AT (1) ATE375796T1 (de)
AU (1) AU2003227858A1 (de)
BR (1) BR0309139A (de)
CA (1) CA2481272A1 (de)
DE (1) DE60316927T2 (de)
GB (1) GB0208129D0 (de)
IL (1) IL164092A0 (de)
MX (1) MXPA04009885A (de)
NO (1) NO20043774L (de)
PL (1) PL372986A1 (de)
WO (1) WO2003086409A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0325957D0 (en) * 2003-11-06 2003-12-10 Arakis Ltd The treatment of pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL96613A0 (en) * 1989-12-18 1991-09-16 Merck & Co Inc Pharmaceutical compositions containing benzodiazepine analogs
GB9721746D0 (en) * 1997-10-15 1997-12-10 Panos Therapeutics Limited Compositions

Also Published As

Publication number Publication date
JP2005529106A (ja) 2005-09-29
GB0208129D0 (en) 2002-05-22
DE60316927D1 (de) 2007-11-29
AU2003227858A1 (en) 2003-10-27
ATE375796T1 (de) 2007-11-15
MXPA04009885A (es) 2004-12-07
PL372986A1 (en) 2005-08-08
BR0309139A (pt) 2005-02-01
EP1492540B1 (de) 2007-10-17
DE60316927T2 (de) 2008-07-24
WO2003086409A1 (en) 2003-10-23
EP1492540A1 (de) 2005-01-05
IL164092A0 (en) 2005-12-18
CA2481272A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
WO2004056305A3 (en) Administration of capsaicinoids
EA200700214A1 (ru) Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией
MXPA05006670A (es) Administracion de capsaicinoides.
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
CY1109229T1 (el) Χρηση σπογγοσινης (2-μεθοξυαδενοσινης) για τη θεραπεια πονου, συγκεκριμενα υπερευαισθησιας στο πονο
BR0205722A (pt) Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor
NO20032027L (no) Effektive antitumorbehandlinger
WO2004039325A3 (en) Treatment of pain with jnk inhibitors
SE0400184D0 (sv) New therapeutical use
GB0020504D0 (en) Therapeutic method
BR0307022A (pt) Método de tratamento de um paciente que precisa de analgesia
TW200420290A (en) Methods for the treatment, prevention and management of macular degeneration
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
SE9902597D0 (sv) New use
TW200503683A (en) Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
GEP201606538B (en) Preoperative treatment of post operative pain
DK1077683T3 (da) Antidepressiv behandling
AU2001236529A1 (en) Combination therapy for cancer
NO20043774L (no) The use of devazenide as analgesic agent
EE200200549A (et) Jagatud doosi teraapia veresooni kahjustava aktiivsusega
EA200401454A1 (ru) Новая комбинация из обратимо действующих ингибиторов протонного насоса и используемых в терапии дыхательных путей лекарственных веществ, предназначенных для лечения респираторных заболеваний
AU2003281257A8 (en) A novel use of rapamycin and structural analogues thereof
TW200501958A (en) A therapeutic agent for treating a behavioral disorder
FI20010233A0 (fi) Menetelmä sydämen vajaatoiminnan hoitoon
TW200509922A (en) Methods of therapeutic treatment using amounts of retinoid components

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application